405 related articles for article (PubMed ID: 16610794)
21. Imidazolylchromanones containing non-benzylic oxime ethers: synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii.
Babazadeh-Qazijahani M; Badali H; Irannejad H; Afsarian MH; Emami S
Eur J Med Chem; 2014 Apr; 76():264-73. PubMed ID: 24583607
[TBL] [Abstract][Full Text] [Related]
22. 3D QSAR CoMFA/CoMSIA and docking studies on azole dione derivatives, as anti-cancer inhibitors.
Anugolu RK; Gunda SK; Mahmood S
Int J Comput Biol Drug Des; 2012; 5(2):111-36. PubMed ID: 22854121
[TBL] [Abstract][Full Text] [Related]
23. [Synthesis and antifungal activity of 1-(2-[(4-substituted-phenyl) methoxy]-2-(substituted-phenyl) ethyl)-1H-azoles].
Wu QY; Li K; Liu CM; Liu GX; Wang XY
Yao Xue Xue Bao; 1993; 28(9):661-7. PubMed ID: 8010011
[TBL] [Abstract][Full Text] [Related]
24. Recent developments in azole compounds as antibacterial and antifungal agents.
Peng XM; Cai GX; Zhou CH
Curr Top Med Chem; 2013 Aug; 13(16):1963-2010. PubMed ID: 23895097
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, antifungal activity, and docking study of some new 1,2,4-triazole analogs.
Sangshetti JN; Lokwani DK; Sarkate AP; Shinde DB
Chem Biol Drug Des; 2011 Nov; 78(5):800-9. PubMed ID: 21752200
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of triazole derivatives as potential antifungal agent.
Chai X; Yang G; Zhang J; Yu S; Zou Y; Wu Q; Zhang D; Jiang Y; Cao Y; Sun Q
Chem Biol Drug Des; 2012 Sep; 80(3):382-7. PubMed ID: 22531027
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and fungicidal activity of enantiomerically pure (R)- and (S)-silicon-containing azole fungicides.
Itoh H; Furukawa Y; Tsuda M; Takeshiba H
Bioorg Med Chem; 2004 Jul; 12(13):3561-7. PubMed ID: 15186840
[TBL] [Abstract][Full Text] [Related]
28. Design and Synthesis of New Antifungals Based on N-Un-substituted Azoles as 14α Demethylase Inhibitor.
Davood A; Rahimi A; Iman M; Azerang P; Sardari S; Mahboubi A
Curr Comput Aided Drug Des; 2021; 17(2):235-243. PubMed ID: 32065093
[TBL] [Abstract][Full Text] [Related]
29. 3D-QSAR and molecular mechanics study for the differences in the azole activity against yeastlike and filamentous fungi and their relation to P450DM inhibition. 1. 3-substituted-4(3H)-quinazolinones.
Fratev F; Benfenati E
J Chem Inf Model; 2005; 45(3):634-44. PubMed ID: 15921453
[TBL] [Abstract][Full Text] [Related]
30. A new, broad-spectrum azole antifungal: posaconazole--mechanisms of action and resistance, spectrum of activity.
Hof H
Mycoses; 2006; 49 Suppl 1():2-6. PubMed ID: 16961575
[TBL] [Abstract][Full Text] [Related]
31. Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine?
Hof H
Drug Resist Updat; 2008; 11(1-2):25-31. PubMed ID: 18325827
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and activities of naphthalimide azoles as a new type of antibacterial and antifungal agents.
Zhang YY; Zhou CH
Bioorg Med Chem Lett; 2011 Jul; 21(14):4349-52. PubMed ID: 21669530
[TBL] [Abstract][Full Text] [Related]
33. Docking analysis of a series of cytochrome P-450(14) alpha DM inhibiting azole antifungals.
Talele TT; Hariprasad V; Kulkarni VM
Drug Des Discov; 1998 May; 15(3):181-90. PubMed ID: 9689500
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, in vitro antifungal activity and in silico study of 3-(1,2,4-triazol-1-yl)flavanones.
Emami S; Shojapour S; Faramarzi MA; Samadi N; Irannejad H
Eur J Med Chem; 2013 Aug; 66():480-8. PubMed ID: 23831810
[TBL] [Abstract][Full Text] [Related]
35. Improved model of lanosterol 14alpha-demethylase by ligand-supported homology modeling: validation by virtual screening and azole optimization.
Sheng C; Wang W; Che X; Dong G; Wang S; Ji H; Miao Z; Yao J; Zhang W
ChemMedChem; 2010 Mar; 5(3):390-7. PubMed ID: 20157915
[TBL] [Abstract][Full Text] [Related]
36. Antifungal activity of bicyclic heterocyclic-1,2-diazole.
Singh Y; Chaurasia L; Nayal SS
Indian J Exp Biol; 2000 May; 38(5):516-8. PubMed ID: 11272421
[TBL] [Abstract][Full Text] [Related]
37. Insights into the interaction and binding mode of a set of antifungal azoles as inhibitors of potential fungal enzyme-based targets.
Guerrero-Perilla C; Bernal FA; Coy-Barrera E
Mol Divers; 2018 Nov; 22(4):929-942. PubMed ID: 29959628
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antifungal activity of 1-[(2-benzyloxy)phenyl]-2-(azol-1-yl)ethanone derivatives: exploring the scaffold flexibility.
Emami S; Kazemi-Najafabadi M; Pashangzadeh S; Foroumadi A; Faramarzi MA; Samadi N; Falahati M; Fateh R; Ashrafi-Khozani M
Chem Biol Drug Des; 2011 Dec; 78(6):979-87. PubMed ID: 21920030
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and structure-activity relationships of new triazole derivatives containing N-substituted phenoxypropylamino side chains.
Wang S; Jin G; Wang W; Zhu L; Zhang Y; Dong G; Liu Y; Zhuang C; Miao Z; Yao J; Zhang W; Sheng C
Eur J Med Chem; 2012 Jul; 53():292-9. PubMed ID: 22560626
[TBL] [Abstract][Full Text] [Related]
40. Identification of the structural requirements of the receptor-binding affinity of diphenolic azoles to estrogen receptors alpha and beta by three-dimensional quantitative structure-activity relationship and structure-activity relationship analysis.
Demyttenaere-Kovatcheva A; Cronin MT; Benfenati E; Roncaglioni A; Lopiparo E
J Med Chem; 2005 Dec; 48(24):7628-36. PubMed ID: 16302803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
